ResearcherHaukeland University HospitalNo recent work listed
Odd Helge Gilja
Matched on ORCID iD 0000-0002-0436-0383; OpenAlex author ID A5042861101. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper
Papers 7
- SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma? Co-author DOI 10.3390/pharmaceutics14010098↗
- Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells. Co-author DOI 10.3390/pharmaceutics12020141↗
- Low-Intensity Sonoporation-Induced Intracellular Signalling of Pancreatic Cancer Cells, Fibroblasts and Endothelial Cells. Co-author DOI 10.3390/pharmaceutics12111058↗
- Sonoporation with Acoustic Cluster Therapy (ACT®) induces transient tumour volume reduction in a subcutaneous xenograft model of pancreatic ductal adenocarcino… Co-author DOI 10.1016/j.jconrel.2016.11.019↗
- A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. Last author DOI 10.1016/j.jconrel.2016.10.007↗
- Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft. Co-author DOI 10.1007/s11307-013-0672-5↗
- Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. Co-author DOI 10.1118/1.4808149↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Spiros Kotopoulis · 7 shared papers, 2013–2022 · strength 0.58
- Paper SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarc… DOI 10.3390/pharmaceutics14010098↗
- Paper Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells. DOI 10.3390/pharmaceutics12020141↗
- Paper Low-Intensity Sonoporation-Induced Intracellular Signalling of Pancreatic Cancer Cells, Fibroblasts and Endothelial Cel… DOI 10.3390/pharmaceutics12111058↗
- Emmet McCormack · 6 shared papers, 2014–2022 · strength 0.54
- Paper SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarc… DOI 10.3390/pharmaceutics14010098↗
- Paper Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells. DOI 10.3390/pharmaceutics12020141↗
- Paper Low-Intensity Sonoporation-Induced Intracellular Signalling of Pancreatic Cancer Cells, Fibroblasts and Endothelial Cel… DOI 10.3390/pharmaceutics12111058↗
- Tormod Karlsen Bjånes · 3 shared papers, 2016–2022 · strength 0.31
- Paper SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarc… DOI 10.3390/pharmaceutics14010098↗
- Paper Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells. DOI 10.3390/pharmaceutics12020141↗
- Paper A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic canc… DOI 10.1016/j.jconrel.2016.10.007↗
- Georg Gjorgji Dimcevski · 4 shared papers, 2013–2022 · strength 0.29
- Paper SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarc… DOI 10.3390/pharmaceutics14010098↗
- Paper A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic canc… DOI 10.1016/j.jconrel.2016.10.007↗
- Paper Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. DOI 10.1118/1.4808149↗
- Ragnhild Haugse · 2 shared papers, 2020–2022 · strength 0.26
- Paper SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarc… DOI 10.3390/pharmaceutics14010098↗
- Paper Low-Intensity Sonoporation-Induced Intracellular Signalling of Pancreatic Cancer Cells, Fibroblasts and Endothelial Cel… DOI 10.3390/pharmaceutics12111058↗
- Michiel Postema · 3 shared papers, 2013–2016 · strength 0.14
- Paper A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic canc… DOI 10.1016/j.jconrel.2016.10.007↗
- Paper Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. DOI 10.1118/1.4808149↗
- Paper Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenog… DOI 10.1007/s11307-013-0672-5↗
- Bettina Riedel · 1 shared paper, 2020 · strength 0.11
- Dag Hoem · 2 shared papers, 2013–2016 · strength 0.10
- Paper A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic canc… DOI 10.1016/j.jconrel.2016.10.007↗
- Paper Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. DOI 10.1118/1.4808149↗
- Anders Molven · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.